Team GB Olympic medallist raises £5m to make health tech as common as iPhone
Olympic medallist turned health tech entrepreneur Andrew Steele has raised nearly £5m ahead of the US launch of his latest venture, Stride. Steele – part of the Team GB 4 x 400m relay squad awarded bronze in Beijing 2008 – co-founded genetic testing firm DNAfit and sold it to David Beckham-backed global giant Prenetics for [...]
Andrew Steele, a former Olympic medallist and entrepreneur, has raised nearly £5 million to launch his health tech startup, Stride. Steele, a member of the Team GB 4 x 400m relay squad that won bronze at the 2008 Beijing Olympics, co-founded genetic testing company DNAfit, which was later acquired by a global firm backed by David Beckham for $10 million in 2018.
Stride provides comprehensive health monitoring, including DNA, gut, and blood tests, as well as consultations and supplements. In its latest funding round, Stride secured £4.6 million from investors, including Innovate UK and Morgan Stanley Inclusive & Sustainable Ventures. Steele believes that within a decade, health monitoring could become as commonplace as owning an iPhone, as wearable technology becomes more accessible and affordable.
The business rationale behind Stride is that continuous health monitoring and improvement will continue to grow in popularity and have a significant impact on preventing disease, potentially even larger than eradicating cancer. Steele, known for his drive to succeed following the 2008 Olympics, believes that the right level of medical testing and support can lead to a lifelong commitment to health and wellness.
Written by urgent.news from City AM's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
